News

Home / News

Announcement of the BOD resolution on issuance of new shares through capitalization of earnings on behalf of TOP PHARM.MEDICALW

2025.2.19

1.Date of the board of directors resolution:2025/02/19

2.Source of capital increase funds:Increase by capitalization of 2024 earnings.

3.Whether to adopt shelf registration(Yes, please state issuance period/No):No

4.Total monetary value of the issuance and number of shares issued (shares issued not including those distributed to employees if consisting in capital increase from earnings or capital surplus):
Total monetary value of the issuance of NT$24,795,000
with the number of shares issued of 2,479,500 shares.

5.If adopting shelf registration, monetary value and number of shares to be issued this time:None

6.The remaining monetary value and shares after this issuance when adopting shelf registration:None

7.Par value per share:NT$10.

8.Issue price:None

9.Number of shares subscribed for by or allocated to employees:None

10.Number of shares publicly sold:None

11.Ratio of shares subscribed by or allotted as stock dividends to existing shareholders:500 shares/per thousand shares as stock grants

12.Handling method for fractional shares and shares unsubscripted for by the deadline:Authorized the Chairman to contact certain persons to purchase shares at the face value per share

13.Rights and obligations of these newly issued shares:Same as the common stocks originally issued.

14.Utilization of the funds from the capital increase:For the Company's business development needs.

15.Any other matters that need to be specified:After approval by the shareholders' meeting, the Board of Directors is authorized to determine the capital increase record date, distribution date, and other related matters.